enow.com Web Search

  1. Ad

    related to: treatment for chronic refractory cough

Search results

  1. Results from the WOW.Com Content Network
  2. Why are so many New Yorkers coughing? What's happening ... - AOL

    www.aol.com/why-many-yorkers-coughing-whats...

    Still, another form of illness called chronic refractory cough doesn’t respond to treatment. It involves cough nerves that are hypersensitive to triggers that don’t make others cough, such as ...

  3. US FDA declines to approve Merck's chronic cough drug - AOL

    www.aol.com/news/us-fda-declines-approve-mercks...

    The health regulator concluded the company's application for the drug, gefapixant, did not meet substantial evidence of effectiveness for treating refractory chronic cough and unexplained chronic ...

  4. FDA panel flags insufficient data for Merck's chronic cough drug

    www.aol.com/news/us-fda-panel-votes-against...

    If approved, Merck's drug is up against GSK-owned camlipixant, which is in late-stage development for the treatment of chronic cough with anticipated regulatory approval and launch in 2026.

  5. Chronic cough - Wikipedia

    en.wikipedia.org/wiki/Chronic_cough

    The prevalence of chronic cough in many communities in Europe and the U.S. is 9–33% of the population. Chronic cough is three times more common in those who smoke compared to people who never smoke. [1] The most important risk factors for chronic cough are tobacco smoking and working in a dusty job. [30]

  6. Gefapixant - Wikipedia

    en.wikipedia.org/wiki/Gefapixant

    Gefapixant, sold under the brand name Lyfnua, is a medication used to treat chronic (long-term) cough. [1] It acts as an antagonist of the P2RX3 receptor. [2] [3] [4] It was approved for medical use in the European Union in September 2023. [1]

  7. Post-nasal drip - Wikipedia

    en.wikipedia.org/wiki/Post-nasal_drip

    Treatment options depend on the nature of an individual's post-nasal drip and its cause. Antibiotics may be prescribed if the PND is the result of bacterial sinusitis. [ 8 ] In cases where PND is caused by allergic rhinitis or irritant rhinitis, avoidance of allergens or irritating factors such as dander, cigarette smoke, and cleaning supplies ...

  8. Merck's Chronic Cough Candidate Achieves Goals in Phase III - AOL

    www.aol.com/news/mercks-chronic-cough-candidate...

    Merck's (MRK) two phase III studies on gefapixant (MK-7264) for the treatment of refractory or unexplained chronic cough meet the primary efficacy endpoints.

  9. Postinfectious cough - Wikipedia

    en.wikipedia.org/wiki/Postinfectious_cough

    A postinfectious cough is a lingering cough that follows a respiratory tract infection, such as a common cold or flu and lasting up to eight weeks. Postinfectious cough is a clinically recognized condition represented within the medical literature.

  1. Ad

    related to: treatment for chronic refractory cough